Status:
UNKNOWN
TaiChi-DTx for Treating Long Covid Symptoms
Lead Sponsor:
Tim Shi
Conditions:
Fatigue
Dyspnea
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (L...
Detailed Description
The randomized controlled trial will be conducted to evaluate the effectiveness of a Multi-domain Tai Chi Digital Therapy for treating the individuals suffering from the long term COVID-19 syndrome (L...
Eligibility Criteria
Inclusion
- Clinical diagnosis with SARS-CoV2 infection via PCR during the past 3 to 6 months
- Must be Grade 2 and Grade 3 assessed by the Post-COVID-19 Functional Status (PCFS) Scale
Exclusion
- Admitted in the Intensive Care Unit due to SARS-COV2 infection or any other serve illness
- Psychiatric diseases and somatic co-morbidities
- COVID-19 infections or co-morbidities started or exacerbated during the same time
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT05419219
Start Date
June 1 2022
End Date
December 31 2023
Last Update
February 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tim Shi
Ellicott City, Maryland, United States, 21042